Cargando…
Acute myocardial infarction associated to DPP-4 inhibitors
INTRODUCTION: Diabetes mellitus is associated with cardiovascular disease. Anti-diabetic therapy has a limited capability (if any) of changing the incidence of either death or major cardiovascular disease, and cardiovascular safety concerns have been raised. We aimed at identifying episodes of acute...
Autores principales: | Nunes, J P L, Rodrigues, J D, Melão, F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
EDIMES Edizioni Internazionali Srl
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4181279/ https://www.ncbi.nlm.nih.gov/pubmed/25279360 |
Ejemplares similares
-
Comparison of SGLT2 inhibitors with DPP-4 inhibitors combined with metformin in patients with acute myocardial infarction and diabetes mellitus
por: Lyu, Young Sang, et al.
Publicado: (2023) -
Correction: Comparison of SGLT2 inhibitors with DPP4 inhibitors combined with metformin in patients with acute myocardial infarction and diabetes mellitus
por: Lyu, Young Sang, et al.
Publicado: (2023) -
The impact of DPP-4 inhibitors on long-term survival among diabetic patients after first acute myocardial infarction
por: Wang, Mei-Tzu, et al.
Publicado: (2017) -
A Novel Indicator of Myocardial Injury after Acute Myocardial Infarction: ‘DPP-3’
por: Ozden, Ozge, et al.
Publicado: (2022) -
Effects of DPP4 Inhibitor in Platelet Reactivity and Other Cardiac Risk Markers in Patients with Type 2 Diabetes and Acute Myocardial Infarction
por: Genestreti, Paulo R. Rizzo, et al.
Publicado: (2022)